KPIs & Operating Metrics(New)

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

National Health Investors (NHI) Shares Repurchased (2022)

National Health Investors filings provide 1 years of Shares Repurchased readings, the most recent being $82.0 million for Q3 2022.

On a quarterly basis, Shares Repurchased changed N/A to $82.0 million in Q3 2022 year-over-year; TTM through Dec 2023 was $82.0 million, a 0.0% change, with the full-year FY2022 number at $152.0 million, changed N/A from a year prior.
Shares Repurchased hit $82.0 million in Q3 2022 for National Health Investors.
In the past five years, Shares Repurchased ranged from a high of $82.0 million in Q3 2022 to a low of $82.0 million in Q3 2022.